pimonidazole: Clinical Trials

14 trials of pimonidazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 2 active not recruiting, 2 withdrawn. 5 Not applicable, 4 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 2, Completed 2, Recruiting 1
Phase 24Completed 1, Suspended 1, Unknown 1, Withdrawn 1
Early Phase 11Withdrawn 1
Phase 11Suspended 1

Follow pimonidazole: new trials by email Literature Review of pimonidazole trials Research Report on pimonidazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Hypoxia in Primary Melanoma
Pimonidazole - Melanoma
RecruitingYana Najjar502025-04-092026-06-10
A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers
fMRI, Oral Pimonidazole - Squamous Cell Carcinoma of Head and Neck
Not applicableRecruitingUniversity Health Network, Toronto602024-01-292026-08-06
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
Pimonidazole, Surgical Resection - Pancreatic Cancer, Resectable Pancreatic Cancer
Early Phase 1WithdrawnH. Lee Moffitt Cancer Center and Research Institute2021-04-012021-02-08
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
Pimonidazole - Melanoma
RecruitingYana Najjar202021-02-242026-06-11
FAZA PET/MRI Sarcoma
18F-FAZA, Pimonidazole - Sarcoma
Not applicableActive not recruitingUniversity Health Network, Toronto702018-03-272026-08-10
Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer
(18)F-Fluoroazomycin arabinoside, Pimonidazole - Tongue Cancer
Phase 1 / Phase 2SuspendedSunnybrook Health Sciences Centre102018-01-252024-08-12
Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours
Hypoxia marker - Cancer
Not applicableCompletedInstitute of Cancer Research, United Kingdom212017-11-102019-12-23
Hypoxia Analysis in Head and/or Neck Cancer
Pimonidazole - Head and Neck Cancer
Phase 2UnknownMarius Gustav Bredell102015-04-012016-06-17
Biomarker Correlates of Hypoxia in Metastatic Melanoma
Pimonidazole hydrochloride (Hypoxyprobe™-1), Optional 18F-FMISO PET scan (18F-fluoromisonidazole), Surgical Resection of Melanoma Metastases - Melanoma, Skin Cancer
Phase 2WithdrawnH. Lee Moffitt Cancer Center and Research Institute2014-10-012016-05-09
Prostate Hypoxia - TIC
Pimonidazole - Prostate Cancer
Not applicableActive not recruitingUniversity Health Network, Toronto392014-09-012026-06-23
Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
Fluvastatin, Pimonidazole - Prostate Cancer
Phase 2CompletedUniversity Health Network, Toronto332014-02-012017-10-26
RHYTHM-I: Investigating Hypoxia in Rectal Tumours
Pimonidazole, F-MISO PET, pCT - Hypoxia in Rectal Cancer
Not applicableCompletedUniversity of Oxford142013-10-012017-03-13
Role of Nox2 in CNI-induced Renal Fibrosis
Hypoxyprobe-1 - Kidney Disease
CompletedUniversity of Wisconsin, Madison82012-11-302019-10-14
Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole
Pimonidazole hydrochloride - Pancreatic Cancer
CompletedUniversity Health Network, Toronto2002010-10-012026-07-10

Conditions studied

Hypoxia (4)  ·  Melanoma (3)  ·  Pancreatic Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Head and Neck Neoplasms (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Sarcoma (1)  ·  Skin Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Tongue Neoplasms (1)

Sponsors

University Health Network, Toronto (5)  ·  H. Lee Moffitt Cancer Center and Research Institute (2)  ·  Yana Najjar (2)  ·  Institute of Cancer Research, United Kingdom (1)  ·  Marius Gustav Bredell (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  University of Oxford (1)  ·  University of Wisconsin, Madison (1)

Countries

Canada (6)  ·  United States (4)  ·  United Kingdom (2)  ·  Switzerland (1)

Top investigators

Alejandro Berlin, MD. (1)  ·  Arjang Djamali, MD,MS,FASN (1)  ·  Ian Poon, MD, FRCPC (1)  ·  Jonathan Zager, M.D. (1)  ·  Marius Bredell (1)  ·  Navita Somaiah (1)  ·  Neesha Dhani, MD (1)  ·  Sarah Hoffe, MD (1)  ·  Tim Maughan (1)  ·  Yana M Najjar, MD (1)  ·  Yana Najjar, MD (1)

Results publications

PMID 26325106, PMID 32203069

NIH funding

R01DK092454 (1)